Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

OptimizeRx Corp (OPRX) Stock Forecast 2025 - AI Price Prediction & Analysis

OptimizeRx Corp (OPRX) AI Stock Price Forecast & Investment Analysis

OptimizeRx Corp Stock Price Chart and Technical Analysis

Loading OptimizeRx Corp interactive price chart and technical analysis...

OptimizeRx Corp (OPRX) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

OptimizeRx Corp (Stock Symbol: OPRX) is a leading company in the Trade & Services sector , specifically operating within the Services-Business Services, NEC industry. The organization employs approximately 106 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $88 million generating a -27.4% net profit margin .

Market Capitalization: $240 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -2.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for OptimizeRx Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

OptimizeRx Corp strategically competes in the highly dynamic Services-Business Services, NEC marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company demonstrates robust operational efficiency through strong free cash flow generation of $3 million annually The company maintains a healthy 62.6% gross margin, indicating strong pricing power and operational efficiency.

OptimizeRx Corp (OPRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for OptimizeRx Corp stock analysis.

Loading OptimizeRx Corp comprehensive fundamental analysis and insider trading data...

Deep dive into OptimizeRx Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if OptimizeRx Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For OptimizeRx Corp: With a P/E ratio of -4.63, the market sees the stock as potentially undervalued.

P/E Ratio -4.63x
P/B Ratio 2.06x
Market Cap $240M
EPS $-1.35
Book Value/Share $6.29
Revenue/Share $0.08
FCF/Share $-0.39
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently OptimizeRx Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For OptimizeRx Corp: An ROE of -2.2% indicates room for improvement in shareholder value creation.

ROE -2.2%
ROA -2.1%
ROIC -2.2%
Gross Margin 62.6%
Operating Margin -32.0%
Net Margin -27.4%
EBT Margin -4.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess OptimizeRx Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For OptimizeRx Corp: A current ratio of 16.39 indicates strong liquidity.

Current Ratio 16.39x
Quick Ratio 15.72x
D/E Ratio 0.01x
Financial Leverage 1.05x
Interest Coverage -1.2x
Working Capital $23M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal OptimizeRx Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For OptimizeRx Corp: Free cash flow of $3M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $3M
Free Cash Flow $3M
FCF/Sales 4.2%
CapEx/Sales 0.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively OptimizeRx Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For OptimizeRx Corp: An asset turnover of 0.48x suggests room for improvement in asset utilization.

Asset Turnover 0.48x
Receivables Turnover 3.8x
Fixed Assets Turnover 181.7x
Days Sales Outstanding 97 days
Payables Period 54 days
Understanding Financial Statement Data

What these metrics mean: Key figures from OptimizeRx Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For OptimizeRx Corp: With annual revenue of $88M, OptimizeRx Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $88M
Operating Income $-28M
Net Income $-24M
R&D Expense $3M
SG&A Expense $58M
Cost of Goods Sold $13M
Balance Sheet Highlights ($ Millions)
Total Current Assets $82M
Cash & Short-term Investments $64M
Total Liabilities $5M
Accounts Receivable $14M
Dividend & Shareholder Information
Shares Outstanding 18M
Growth Metrics (YoY)
EPS Growth -21.8%

Latest OptimizeRx Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting OptimizeRx Corp (OPRX) stock price and investment outlook.

📰 We are currently updating our news feed for OptimizeRx Corp. Check back soon for the latest market analysis and company updates.

OptimizeRx Corp Competitors & Peer Analysis - Trade & Services Sector

Comparative analysis of OptimizeRx Corp against industry peers and competitors in the Trade & Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACCD Unlock Forecast $573M -2.9x 1.8x
ACN Unlock Forecast $167463M 21.1x 5.5x
ACVA Unlock Forecast $1936M -45.1x 4.3x
ADV Unlock Forecast $486M -8.4x 0.6x
ADVWW Unlock Forecast $5M x 0.0x
AFBL Unlock Forecast $40M x x
AKAM Unlock Forecast $11505M 26.4x 2.5x
ALIT Unlock Forecast $0M -13.8x 0.0x
AMTM Unlock Forecast $6257M x 1.4x
AMWL Unlock Forecast $116M -1.7x 0.4x
ASFH Unlock Forecast $85M x 44.5x
BABA Unlock Forecast $2889197M x 2.9x
BABAF Unlock Forecast $348497M x 0.3x
BAER Unlock Forecast $-14M -3.0x -0.3x
BAERW Unlock Forecast $5M x 0.0x
BAOS Unlock Forecast $4M x 0.1x
BCRD Unlock Forecast $146M x 17.9x
BR Unlock Forecast $29807M 35.5x 11.2x
CART Unlock Forecast $13094M 26.8x 4.0x
CASS Unlock Forecast $586M 23.1x 2.4x
CBZ Unlock Forecast $4095M 37.5x 2.2x
CCCP Unlock Forecast $0M x x
CJMB Unlock Forecast $22M x 3.7x
CNDT Unlock Forecast $531M 26.5x 0.7x
CNXC Unlock Forecast $3298M 13.5x 0.8x
CPAY Unlock Forecast $22943M 21.9x 5.8x
CREG Unlock Forecast $6M -5.4x 0.1x
CSGP Unlock Forecast $36579M 351.0x 4.3x
CTEV Unlock Forecast $702M x 47.4x
CURR Unlock Forecast $67M x -1.0x
DASH Unlock Forecast $106727M 136.7x 12.0x
DBMM Unlock Forecast $2M x x
DHX Unlock Forecast $133M 55.6x 1.3x
DWIS Unlock Forecast $20M x x
EBAY Unlock Forecast $42518M 19.5x 9.0x
EDXC Unlock Forecast $2M x x
EEX Unlock Forecast $1004M 127.1x 2.6x
ETSY Unlock Forecast $5441M 33.2x -6.9x
EXLS Unlock Forecast $7121M 30.1x 6.7x
FI Unlock Forecast $78080M 23.1x 3.1x
FICO Unlock Forecast $37165M 58.8x -33.2x
FIS Unlock Forecast $36010M 404.6x 2.5x
FLYW Unlock Forecast $1608M 235.5x 2.0x
FOUR Unlock Forecast $8440M -87.9x 10.4x
FTFT Unlock Forecast $13M -0.5x 1.2x
FVRR Unlock Forecast $886M x 2.2x
GBUX Unlock Forecast $65M x x
GETY Unlock Forecast $824M 60.6x 1.4x
GPN Unlock Forecast $20102M 21.8x 0.9x
HGBL Unlock Forecast $68M 19.1x 1.0x
HQY Unlock Forecast $7832M 53.7x 3.7x
IIIV Unlock Forecast $0M -106.3x 0.0x
IMXI Unlock Forecast $286M 12.7x 2.1x
INVU Unlock Forecast $37M x 2.1x
INVUP Unlock Forecast $48334M x 2776.6x
JANL Unlock Forecast $48M 14.9x 2.1x
LQDT Unlock Forecast $990M 37.2x 4.8x
LUCN Unlock Forecast $28M x x
LYFT Unlock Forecast $7126M 77.3x 9.7x
MA Unlock Forecast $540635M 39.9x 68.8x
MAX Unlock Forecast $8915M -28.2x 203.0x
MCHX Unlock Forecast $0M -17.5x 0.0x
MCOM Unlock Forecast $0M x 0.0x
MDCE Unlock Forecast $1M x x
MELI Unlock Forecast $120648M 58.8x 21.1x
MMS Unlock Forecast $5196M 16.4x 2.9x
MOGU Unlock Forecast $2983M x 5.0x
MPLN Unlock Forecast $324M -0.6x 3.9x
MSCI Unlock Forecast $43012M 36.5x -46.8x
NOTE Unlock Forecast $0M -6.1x 0.0x
NUTX Unlock Forecast $684M 10.2x 3.5x
OLB Unlock Forecast $4M -0.9x 1.7x
OLO Unlock Forecast $1849M -64.3x 2.6x
OPRX Unlock Forecast $240M -4.6x 2.1x
PAY Unlock Forecast $4845M 86.4x 9.4x
PAYO Unlock Forecast $2582M 25.9x 3.4x
PAYS Unlock Forecast $292M 43.0x 6.9x
PDD Unlock Forecast $576735M x 20.3x
PHR Unlock Forecast $1841M -20.5x 6.5x
PRTH Unlock Forecast $653M 17.7x -3.7x
PRTHU Unlock Forecast $596M 16.1x x
PSFE Unlock Forecast $M x x
PYPL Unlock Forecast $68419M 14.6x 3.4x
QH Unlock Forecast $401M x 0.9x
QNST Unlock Forecast $902M -42.4x 3.8x
RBA Unlock Forecast $23519M 56.3x 4.3x
RDWR Unlock Forecast $1204M x 3.8x
RELY Unlock Forecast $4138M 293.9x 5.4x
RGP Unlock Forecast $199M 22.9x 0.7x
RMNI Unlock Forecast $445M -24.2x -7.0x
RPAY Unlock Forecast $0M -10.6x 0.0x
RSKD Unlock Forecast $807M x 2.1x
RSSS Unlock Forecast $98M -199.0x 8.7x
SCOR Unlock Forecast $-290M -0.4x -2.0x
SEZL Unlock Forecast $3213M 30.7x 24.6x
SGRP Unlock Forecast $28M 3.9x 1.1x
SOPA Unlock Forecast $6M -0.4x -9.3x
SRCO Unlock Forecast $3M x x
STCN Unlock Forecast $77M 2.6x 0.5x
TC Unlock Forecast $6831M x x
TCOM Unlock Forecast $47350M x 2.9x
TETE Unlock Forecast $0M x 0.0x
TETEU Unlock Forecast $0M x 0.0x
TETEW Unlock Forecast $0M x 0.0x
TGL Unlock Forecast $3M 0.0x 0.1x
TIC Unlock Forecast $1367M x 1.2x
TNET Unlock Forecast $3490M 24.4x 32.6x
TRPCF Unlock Forecast $47767M x 2.9x
UBER Unlock Forecast $206148M 16.3x 9.1x
UK Unlock Forecast $1M x 0.0x
UXIN Unlock Forecast $4771M x x
V Unlock Forecast $1755M 30.9x 0.1x
VVI Unlock Forecast $978M 35.3x 10.1x
WEX Unlock Forecast $6241M 20.4x 6.4x
WNS Unlock Forecast $3435M x 4.1x
WRPT Unlock Forecast $11M x 78.5x
WU Unlock Forecast $2690M 5.9x 32.2x
XBP Unlock Forecast $22M x -1.8x
XBPEW Unlock Forecast $1M x 0.0x
XHLD Unlock Forecast $11M x 2.1x
XMTR Unlock Forecast $1754M -24.7x 4.3x
Z Unlock Forecast $0M -138.1x 0.0x
ZG Unlock Forecast $0M -134.7x 0.0x

Frequently Asked Questions - OptimizeRx Corp Stock Forecast

How accurate are OptimizeRx Corp stock predictions?

Our AI model demonstrates 35% historical accuracy for OPRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence OptimizeRx Corp stock price forecasts?

Our analysis considers OptimizeRx Corp's financial metrics, Trade & Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is OptimizeRx Corp a good investment in 2025?

Based on our AI analysis, OptimizeRx Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are OptimizeRx Corp forecasts updated?

OptimizeRx Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced OptimizeRx Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for OptimizeRx Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...